原发性上肢深静脉血栓溶栓后胸廓出口减压时机:系统综述
本系统综述比较原发性上肢深静脉血栓患者溶栓后早期(两周内)与延期(两周及以上)胸廓出口减压手术的安全性和有效性。纳入6项研究共126例患者,早期组87例,延期组39例。两组出血并发症、复发血栓及无症状生存率相当,早期减压组最终随访时89%患者症状轻微或无,延期组为90%。
要点
- 早期组出血并发症7%,延期组5%,早期组三分之二出血发生于溶栓后24小时内且围术期使用静脉肝素。
- 术前复发血栓早期组7%、延期组11%;术后复发血栓早期组13%、延期组21%。
- 早期组89%、延期组90%患者最终随访时症状轻微或无,疗效相当。
核心结论
- 基于有限数据,原发性上肢深静脉血栓患者导管导向溶栓后两周内早期减压手术似乎与延期手术同样安全有效。
研究设计与样本
- 系统综述,检索PUBMED、EMBASE和COCHRANE数据库,纳入6项研究共126例患者,早期组(溶栓后两周内手术)87例,延期组(两周及以上)39例。
主要发现
- 早期组出血并发症7%,延期组5%;早期组三分之二出血发生在溶栓后24小时内且围术期使用静脉肝素。
- 术前复发血栓早期组7%、延期组11%;术后复发血栓早期组13%、延期组21%。
- 最终随访时早期组89%、延期组90%患者症状轻微或无。
- 平均随访时间早期组35个月(1-168个月),延期组28个月(1-168个月)。
临床怎么用
- 对于原发性上肢深静脉血栓接受溶栓治疗的患者,可考虑在两周内进行早期减压手术,但需注意溶栓后24小时内手术并合用静脉肝素可能增加出血风险。
局限性
- 纳入研究数量有限(仅6项,126例患者),证据级别有限,结论需谨慎解读。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The optimal timing of decompression surgery after thrombolysis in patients with primary upper extremity deep vein thrombosis (UEDVT) is still a matter of debate. This systematic review compares the safety and efficacy of early intervention versus postponed intervention in patients with primary UEDVT. METHODS: A structured PUBMED, EMBASE, and COCHRANE search was performed for studies reporting on the timing of surgical intervention for primary UEDVT. Studies reporting on timing of decompression surgery in combination with recurrent thrombosis, bleeding complications, and symptom-free survival were included. Two treatment groups were defined; group A received surgical decompression within two weeks after thrombolysis and group B after two weeks or more. All end points were assessed in accordance with the reported outcomes in the included articles. Mean percentages were calculated using descriptive statistics. RESULTS: Six articles (126 patients) were included: 87 patients in group A versus 39 in group B. In group A, bleeding complications occurred in 7% of patients versus 5% in group B. Two-third of the bleeding complications in group A occurred in patients receiving surgical decompression within 24 hr after thrombolysis while kept on intravenous heparin both preoperatively and postoperatively. Reported preoperative recurrent thrombosis was 7% in group A versus 11% in group B, another 13% had postoperative recurrent thrombosis versus 21% in group B. The effectiveness of both treatment strategies was comparable with a total of 89% of patients in group A with minimal or no symptoms at final follow-up compared with 90% in group B. The mean follow-up in group A was 35 months (1-168 months) and 28 months (1-168 months) in group B. CONCLUSIONS: Based on the limited available data presented in this review, early decompression surgery within two weeks after catheter-directed thrombolysis seems as safe and effective as postponed surgical intervention in patients with primary UEDVT.
引用
- de Kleijn RJCMF, Schropp L, Westerink J, et al. Timing of Thoracic Outlet Decompression after Thrombolysis for Primary Upper Extremity Deep Venous Thrombosis: A Systematic Review. Ann Vasc Surg. 2020. PMID: 32035261. doi:10.1016/j.avsg.2020.01.083
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。